The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative selected four new international research projects under a transnational call between 21 countries. JPND aims to tackle one of the biggest challenges facing society, namely that of neurodegenerative diseases, and specifically the optimisation of biomarkers and the harmonisation of their use.
The project, ‘Biomarker based diagnosis of rapid progressive dementias – optimisation of diagnostic protocols’ (DEMTEST), which is proposed by CIBERNED and coordinated by the University Medical Center Göttingen in Germany, counts Molecular and Cellular Neurotechnology group leader José Antonio del Río as one of its partners. His group will contribute by analyzing and harmonizing the Tau samples, a protein associated with microtubules that is implicated in Alzheimer’s disease, of the European Biobanks. The starting meeting will take place in Berlin in June 2012.
For further information, visit www.neurodegenerationresearch.eu/initiatives/biomarker-transnational-call/results-of-funding-call.
